Company intelligence / Profile preview
LFB Group
Les Ulis, Essonne, Francegroupe-lfb.com ↗
- Ownership
- Public · BELFB
- Employees
- ~2900
- Development stage
- Commercial
01
Overview
LFB currently markets about fifteen biomedicinal products in more than 30 countries, focusing on three major therapeutic areas: immunology, haemostasis, and intensive care[3][9].
- Therapeutic areas
- HematologyImmunology
- Modalities
- Plasma-derived medicinal productsRecombinant proteins
- Industry
- Biotech
02
Drug pipeline
10 assets9 more assets in the full pipeline.
03
Partnerships
Sanquin (Dutch fractionation company)ImmunoTek (for plasma supply in USA)[6]
Beyond the preview
Go deeper on LFB Group.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on LFB Group.